环氧化酶-2与乳腺癌的研究进展
出处
《山西医科大学学报》
CAS
2005年第3期381-383,共3页
Journal of Shanxi Medical University
基金
温州医学院科研发展基金资助项目(2003X01)
参考文献29
-
1Greenlee RT, Hill-Harmon BB, Murray T, et al. Cancer statistics,2001[J]. CA Cancer Journal forClinicians, 2001,51(1) :15~36. 被引量:1
-
2郭贵龙,姚榛祥,吴坚.环氧化酶-2基因在人乳腺癌中的表达及临床意义[J].中华医学杂志,2003,83(19):1661-1664. 被引量:38
-
3Egan KM, Stampfer MJ, Giovannucci E, et al. Prospective study of regular asprin use and the risk of breast cancer[J]. J Natl Cancer Inst, 1996,88(12) :988~993. 被引量:1
-
4Harris RE, Namboodiri KK, Farrar WB. Nonsteroidal anti-infammatory drugs and breast cancer[J]. Epidemiology, 1996,7(3) :203~205. 被引量:1
-
5Sharpe CR, Collet JP, McNutt M, et al. Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage[J]. Br J Cancer, 2000,83( 1 ): 112~ 120. 被引量:1
-
6Harris RE, Chlebowske RT, Jackson RD, et al. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the women' s health initiative [J ]. Cancer Res, 2003,63(18) :6096~6101. 被引量:1
-
7Parrett ML, Harris RE, Joarder FS, et al. Cyclooxygenase- 2expression in human breast cancer[J]. Int J Oncology, 1997,10(7) :503~507. 被引量:1
-
8Hwang D, Scollard D, Byme J, et al. Expression of cyclooxygenase - 1 and cyclooxygenase - 2 in human breast cancer[ J ]. J Natl Cancer Inst, 1998,90(6) :455~460. 被引量:1
-
9Subbaramaiah K, Norton L, Gerald W, et al. Cyelooxygenase-2 is overexpressed in HER - 2/neu-positive breast cancer: evidence for involvement of AP - 1 and PEA3 [ J ]. J Biol Chem,2002,277(21 ): 18649~ 18677. 被引量:1
-
10Denkert C, Winzer KJ, Hauptmann S. Prognostic impact of cyclooxygenase- 2 in breast cancer[J]. Clin Breast Cancer, 2004,4(6) :428~433. 被引量:1
二级参考文献20
-
1SambrookJ FritschEF ManiatisT.克隆化基因所表达蛋白质的检测与分析[A].金冬雁 黎孟枫 译.分子克隆实验指南 第3版[C].北京:科学出版社,1992.852-898. 被引量:1
-
2Sawaoka H, Tsuji S, Tsujii M, et al. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest, 1999, 79: 1469-1477. 被引量:1
-
3Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad USA, 1997, 94:3336-3340. 被引量:2
-
4Funato T, Kozawa K, Fujimaki S, et al. Increased sensitivity to cisplatin in gastric cancer by antisense inhibition of the her-2/neu (c-erbB-2 ) gene. Chemotherapy, 2001, 47: 297-303. 被引量:1
-
5Half E, Tang XM, Gwyn K, et al. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res, 2002, 62:1676-1681. 被引量:1
-
6Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res, 2002, 62: 632-635. 被引量:1
-
7Costa C, Soares R, Reis-Filho JS, et al. Cyclooxygenase-2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol, 2002, 55: 429-434. 被引量:1
-
8Schmitt F, Soares R. TGFα and angiogenesis. Am J Surg Pathol, 1999,23: 358-359. 被引量:1
-
9郭贵龙 姚榛祥.P27、Ki—67联合检测对乳腺癌预后的意义[J].中华实验外科杂志,2002,19:273-273. 被引量:1
-
10Liu X, Rose D. Differential expression and regulation of cyclooxygense-1 and -2 in two human breast cancer cell lines. Cancer Res, 1996,56: 5125-5127. 被引量:1
共引文献52
-
1徐维华,汪立鑫.环氧合酶-2与乳腺癌的研究进展[J].中国现代药物应用,2009,3(3):180-181. 被引量:1
-
2郭贵龙,李卓英,尤捷,周素梅,金纯,张筱骅.选择性环氧合酶-2抑制剂nimesulide对人类乳腺癌肿瘤血管形成因子的影响[J].肿瘤研究与临床,2008,20(1):6-9. 被引量:1
-
3吴平,陈念平,黄冰,何惠娟,杨展.环氧化酶-2基因和蛋白在人胃癌组织中的表达及临床意义[J].中国肿瘤临床,2004,31(15):860-863. 被引量:6
-
4郭贵龙,姚榛祥.环氧化酶-2在人乳腺癌中的表达及对肿瘤血管形成的影响[J].中华外科杂志,2004,42(20):1271-1272. 被引量:18
-
5宋伟庆,韩彩丽,周保军,张轶华,陈怡,刘玉,韦金英.COX-2与hMLH1、hMSH2在大肠癌中表达的相关性研究[J].世界华人消化杂志,2005,13(1):105-109. 被引量:6
-
6郭贵龙,张筱骅,姚榛祥.环氧化酶-2抑制剂nimesulide对乳腺癌细胞株增生、凋亡的影响[J].肿瘤研究与临床,2005,17(1):6-9. 被引量:1
-
7郭贵龙,张筱骅,姚榛祥.尼美舒利对二甲基苯并蒽诱导的乳腺癌的影响及机制的实验研究[J].中华外科杂志,2005,43(15):1017-1020. 被引量:4
-
8郭贵龙,李卓英,周素梅,金纯,林包荣,张筱骅.环氧化酶-2在人、大鼠乳腺癌及人乳腺癌细胞株的表达及其意义[J].肿瘤研究与临床,2006,18(5):292-295. 被引量:6
-
9虞长春,吴强,吴正升,凌晓光,杨枫.肝细胞肝癌中COX-2表达与Survivin和Caspase-3的关系[J].安徽医科大学学报,2006,41(4):399-401. 被引量:5
-
10郭贵龙,李卓英,尤捷,张筱骅.Nimesulide对乳腺癌细胞株化疗敏感性的影响及机制研究[J].中华肿瘤防治杂志,2006,13(16):1214-1218. 被引量:1
-
1郭贵龙,张筱骅,姚榛祥.选择性环氧化酶-2抑制剂的抗乳腺癌作用途径[J].中华实验外科杂志,2005,22(3):378-378. 被引量:5
-
2胰、脾[J].中国医学文摘(肿瘤学),2004,18(2):117-118.
-
3孟翠翠,陈晓品,罗治彬.塞来昔布联合替吉奥对胃癌裸鼠移植瘤生长的抑制作用[J].细胞与分子免疫学杂志,2013,29(5):458-461. 被引量:5
-
4辛兵,王敏.选择性环氧化酶-2抑制剂对卵巢癌细胞抑制作用的体内体外研究[J].现代肿瘤医学,2015,23(18):2561-2565. 被引量:8
-
5刘杨,邓婷,胡春宏.选择性环氧化酶-2抑制剂对乳腺癌细胞的化疗增敏作用[J].现代生物医学进展,2009,9(9):1684-1686. 被引量:2
-
6周旭春,唐承薇.不同选择性环氧化酶—2抑制剂对胰腺癌生长的影响[J].胃肠病学,2001,6(C00):101-101.
-
7郭贵龙,李卓英,周素梅,林包荣,张筱骅.Nimesulide对乳腺癌细胞株MMP-2、MMP-9基因表达的影响[J].温州医学院学报,2007,37(1):52-55. 被引量:1
-
8伊雪,朱兰,王献华,郑素芹.核因子-κB、基质金属蛋白酶-9与乳腺癌的侵袭和转移[J].中国煤炭工业医学杂志,2008,11(6):928-930.
-
9李力.宫颈癌与人乳头瘤病毒感染[J].中国实用妇科与产科杂志,2006,22(1):13-15. 被引量:35
-
10佘明金,秦凤展.乳腺癌骨髓微转移的检测及其意义[J].蚌埠医学院学报,2006,31(2):211-215.